WebCSL BEHRINGPatient Assistance Program. Patient assistance programs (PAPs) are programs created by drug companies, such as CSL BEHRING, to offer free or low cost drugs to individuals who are unable to pay for their medication. These Programs may also be called indigent drug programs, charitable drug programs or medication assistance … WebAug 11, 2024 · Ferring Pharmaceuticals issued a voluntary recall of Stimate (desmopressin) nasal spray due to “superpotency” – in other words, amounts of desmopressin being …
1020 First Avenue • King of Prussia, PA 19406
WebCSL Behring Company Profile, Marketing Contacts, Media Spend, Brands. Headquartered in King of Prussia, PA, CSL Behring is one of the largest fully integrated plasma collection companies. CSL Behring's products include coagulation therapies, plasma extenders and immunoglobulins. WebAug 11, 2024 · CSL Behring Biotherapies for Life" URGENT: VOLUNTARY PRODUCT RECALL Subject: Desmopressin Acetate (Nasal Spray) 1.5 mg/mL Stimate@ NDC Number: 0053-6871-00 August 11, 2024 Dear Valued Patient, CSL Behring is committed to ensuring that its products adhere to the highest quality standards. As such, we must flying horse north golf
Find a Plasma Donation Center Near You CSL Plasma
WebSep 9, 2024 · Recently, CSL Behring announced that the company has chosen to end their distribution agreement with Ferring Pharmaceuticals for STIMATE® nasal spray, … WebProduct Identity Stimate Nasal Spray Alternate Names Stimate Nasal Spray 1.2. Relevant identified uses of the substance or mixture and uses advised against ... Company Name CSL Behring L.L.C. 1020 First Avenue PO Box 61501 King of Prussia, PA Emergency 24 hour Emergency Telephone No. Emergency Response: (800) 424-9300 Emergency … WebJul 3, 2024 · The sabbatical is an outgrowth of CSL Behring’s partnership with Penn State to nurture the next generation of biotech professionals. The goal of the partnership is twofold: to establish a state-of-the-art Center of Excellence in Industrial Biotechnology at Penn State, which opened in 2024, and to develop a multidisciplinary biotech curriculum ... flying horse north